Stock Price
1.63
Daily Change
0.04 2.52%
Monthly
1.24%
Yearly
22.56%
Q2 Forecast
1.60

Autolus Therapeutics Ltd reported $-90.33M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AstraZeneca USD 3.08B 754M Mar/2026
Autolus Therapeutics Ltd USD -90.33M 11.21M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Novartis USD 3.16B 747M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Silence Therapeutics USD -11.77M 9.19M Dec/2025